Carregant...
Oral hypoglycemic agents: do the ends justify the means?
BACKGROUND: Glyburide has replaced insulin as the first line of therapy in the treatment of gestational diabetes in the United States. Glyburide and metformin therapies were reported to be comparable to insulin yet also cost-effective, patient-friendly, and potentially compliance-enhancing. Recently...
Guardat en:
| Publicat a: | Matern Health Neonatol Perinatol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4823678/ https://ncbi.nlm.nih.gov/pubmed/27057336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40748-015-0021-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|